{"id":203597,"name":"ALEXION PHARMACEUTICALS","slug":"alexion-pharmaceuticals","state":"CA","country":"United States of America","description":"Biotechnology company; focuses on drugs treating thrombosis and hematological malignancies","totalSpending":355000,"filings":13,"yearlySpending":[{"year":2019,"income":10000},{"year":2020,"income":150000},{"year":2021,"income":195000},{"year":2022,"income":0}],"issues":[{"code":"PHA","display":"Pharmacy"},{"code":"HCR","display":"Health Issues"}],"firms":["THE KPM GROUP DC LLC"],"lobbyists":["PATROSKI LAWSON","BENJAMIN MASON"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["New Technology Add-on Payment (NTAP) for Medicare; Reimbursement issues related to coding (J code and C code)","Discussed CMS reimbursement and New Technology Add-on Payment(NTAP) for prescription drugs.","Medicare Policy and Reimbursement","Medicare Policy and Reimbursement","S.4010 - Creating Hope Reauthorization Act"]}